Phibro Animal Health CorpPAHC
Price$35.87Intrinsic value$32.3710% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $32.37median of 6 methods · middle span $18-$39based on filings through 31 Mar 2026
Market Price $35.87Price as of 1 Oct 2026
Margin of Safety -9.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 13.4% (near-term consensus, capped) · years 2–5: 9.9%/yr (balance of the path).10.6% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 610.1%Yr 710.2%Yr 810.4%Yr 910.5%Yr 1010.6%
9.9% → 10.6%
Years 11–20: glide to long-run rate
Per-year rates
Yr 119.9%Yr 129.1%Yr 138.3%Yr 147.6%Yr 156.8%Yr 166.1%Yr 175.3%Yr 184.5%Yr 193.8%Yr 203.0%
10.6% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)12.6%
Discount rate (cost of equity) 7.9%
Volatility vs market (adjusted beta)0.65

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetPhibro Animal Health CorpPAHCHealth Care
Valuation
P/E14.8×
P/S0.9×
P/B3.7×
EV / Revenue1.3×
EV / EBITDA8.8×
Profitability
Gross margin32.8%
Operating margin11.7%
Net margin6.6%
FCF margin0.6%
Returns
ROE25.9%
ROA6.6%
ROIC10.6%
Growth
Revenue growth (YoY)17.1%
5-yr fwd EPS growth10.6%
Financial strength
Debt / Equity1.61×
Current ratio2.96×
Altman Z-Score3.0
Interest coverage—
Dividend yield0.7%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.